AHA: Baxdrostat Studied in Treatment-Resistant Hypertension
Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study
Only registered members have full access to PracticeUpdate content.